These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15106126)

  • 1. Clinical characteristics and economic costs of patients with painful neuropathic disorders.
    Berger A; Dukes EM; Oster G
    J Pain; 2004 Apr; 5(3):143-9. PubMed ID: 15106126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic characteristics of patients with painful neuropathic disorders in Germany.
    Berger A; Toelle T; Sadosky A; Dukes E; Edelsberg J; Oster G
    Pain Pract; 2009; 9(1):8-17. PubMed ID: 19019057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings.
    Gore M; Dukes E; Rowbotham DJ; Tai KS; Leslie D
    Eur J Pain; 2007 Aug; 11(6):652-64. PubMed ID: 17126045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders.
    Oster G; Berger A; Dukes E; Edelsberg J; McCarberg B
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):163-70. PubMed ID: 15561648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis.
    Gore M; Tai KS; Sadosky A; Leslie D; Stacey BR
    J Med Econ; 2011; 14(4):497-507. PubMed ID: 21682606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study.
    Berger A; Sadosky A; Dukes E; Edelsberg J; Oster G
    BMC Neurol; 2012 Mar; 12():8. PubMed ID: 22394606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings.
    Gore M; Sadosky A; Stacey BR; Tai KS; Leslie D
    Spine (Phila Pa 1976); 2012 May; 37(11):E668-77. PubMed ID: 22146287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec database.
    Lachaine J; Gordon A; Choinière M; Collet JP; Dion D; Tarride JE
    Pain Res Manag; 2007; 12(1):31-7. PubMed ID: 17372632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs.
    Dworkin RH; Malone DC; Panarites CJ; Armstrong EP; Pham SV
    J Pain; 2010 Apr; 11(4):360-8. PubMed ID: 19853529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of contraindicated medical conditions and use of precluded medications in patients with painful neuropathic disorders prescribed amitriptyline.
    Gore M; Dukes E; Rowbotham D; Tai KS; Leslie DL
    Pain Pract; 2006 Dec; 6(4):265-72. PubMed ID: 17129307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia.
    Berger A; Sadosky A; Dukes EM; Edelsberg J; Zlateva G; Oster G
    Am J Manag Care; 2010 May; 16(5 Suppl):S126-37. PubMed ID: 20586521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings.
    Gore M; Tai KS; Sadosky A; Leslie D; Stacey BR
    Pain Pract; 2012 Sep; 12(7):550-60. PubMed ID: 22304678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic characteristics of patients with severe neuropathic pain secondary to failed back surgery syndrome.
    Thomson S; Jacques L
    Pain Pract; 2009; 9(3):206-15. PubMed ID: 19281499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain.
    Kwong WJ; Diels J; Kavanagh S
    Ann Pharmacother; 2010 Apr; 44(4):630-40. PubMed ID: 20197473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting.
    Ritzwoller DP; Ellis JL; Korner EJ; Hartsfield CL; Sadosky A
    Curr Med Res Opin; 2009 Jun; 25(6):1319-28. PubMed ID: 19419344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the prevalence and cost of back pain with neuropathic components in the general population.
    Schmidt CO; Schweikert B; Wenig CM; Schmidt U; Gockel U; Freynhagen R; Tölle TR; Baron R; Kohlmann T
    Eur J Pain; 2009 Nov; 13(10):1030-5. PubMed ID: 19201230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
    Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
    Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis.
    Mehra M; Hill K; Nicholl D; Schadrack J
    J Med Econ; 2012; 15(2):245-52. PubMed ID: 22136441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.